Your organization’s most volatile machinery isn’t on the factory floor or in the server room—it’s sitting at a desk, managing accounts, leading sales calls, and running on fluctuating blood sugar.

In this episode of The Health Intelligence Briefing, we dissect why metabolic health and glucose compliance have evolved from private medical matters into major compound liabilities on enterprise balance sheets. We explore the biological realities of poor glucose regulation—how it acts like microscopic sandpaper on the vascular system—and trace the direct line to skyrocketing health insurance claims, chronic absenteeism, and hidden presenteeism.

In this deep dive, we discuss:

• The True Cost of Inaction: Why employees with unmanaged diabetes can cost organizations over £3,100 ($4,000+) more ...